Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Sorting Through Cellular Statistics
Friday, July 31, 2015
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.

Women’s Immune System Genes Operate Differently from Men’s
Friday, July 31, 2015
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.

Experimental MERS Vaccine Shows Promise in Animal Studies
Thursday, July 30, 2015
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.

HIV Susceptibility Linked to Little-Understood Immune Cell Class
Thursday, July 30, 2015
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.

New Weapon in the Fight Against Blood Cancer
Tuesday, July 28, 2015
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.

Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
Tuesday, July 28, 2015
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.

EU Drug Regulator Recommends 1st License for Malaria Shot
Monday, July 27, 2015
Mosquirix to be used for vaccination of young children, together with established antimalarial interventions.

Horizon Discovery Group to Invest in Cancer Therapeutics
Monday, July 27, 2015
The company have announced that they are set to invest up tp £10 million of leveraged funding over the next two years to identify the next generation of molecular cancer therapeutics.

Xoma's Gevokizumab Fails Phase III Trial
Thursday, July 23, 2015
Xoma have announced that their monoclonal antibody gevokizumab it is co-developing with Servier has failed the Phase III EYEGUARD-B trial in patients with Behçet's disease uveitis.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1535
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!